SITC Cancer Immunotherapy CONNECT

Stay Current with FDA-Approved Immunotherapy Treatments
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program

Madison, Wis. | Live Webcast | Boston | Indianapolis
Seattle | Louisville, Ky. | Pittsburgh



Understand Cancer Immunotherapy With This
Free Online Activity

The Society for Immunotherapy of Cancer’s new online activity explains cancer immunotherapy and the immune system to patients.

Register for the online ACTIVITY


SITC Cancer Immunotherapy Guidelines –
Non-Small Cell Lung Cancer Webinar

Discuss NSCLC immunotherapy treatment guidelines in a free
webinar on Sept. 13 at 1 p.m. EDT.

Learn More and Register


Register for SITC 2018

Attend the the 33rd Annual Meeting & Pre-Conference Programs this Nov. 7–11, 2018 at the Walter E. Washington Convention Center in Washington, D.C.

Learn more


JITC Earns Impact Factor of 8.374

The Journal for ImmunoTherapy of Cancer (JITC) received its first impact factor of 8.374! JITC’s impact factor ranks in the top 8 percent of all journals published in the categories of oncology and immunology.



Learn the Value of 

member-ribbon-v4.pngSee members discuss the benefits of a SITC membership in this new video.

Watch The Video


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • Memorial Sloan Kettering Cancer Center invites you to attend the   2018 Annual Cancer Treatment-Related Adverse Events Symposium  on Friday-Saturday,  October 26-27 , at Zuckerman Research Center in New York.  Systemic anticancer therapies including ...

  • We are currently organizing the 8 th InterAmerican Oncology Conference, "Current Status and Future of Anti-Cancer Therapies" will take place on October  17 th and 18 th , 2019 in Buenos Aires, Argentina. Dres. Alex Adjei (Mayo Clinic, USA),  Román ...

  • Usage of CRISPR/Cris9, an RNA guided DNA gene editing technology has powerful manipulative abilities. It has a special place in genetic engineering in its development. There is current development of this technology for therapeutic applications, particularly ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More